These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A case of severe aplastic anaemia after SARS-CoV-2 vaccination. Cecchi N; Giannotta JA; Barcellini W; Fattizzo B Br J Haematol; 2022 Mar; 196(6):1334-1336. PubMed ID: 34783367 [No Abstract] [Full Text] [Related]
5. Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan. Chen CY; Chen TT; Hsieh CY; Lien MY; Yeh SP; Chen CC Int J Hematol; 2023 Jan; 117(1):149-152. PubMed ID: 36057889 [TBL] [Abstract][Full Text] [Related]
6. Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence? Tabata S; Hosoi H; Murata S; Takeda S; Mushino T; Sonoki T J Autoimmun; 2022 Jan; 126():102782. PubMed ID: 34920343 [TBL] [Abstract][Full Text] [Related]
7. Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination. Kurahashi Y; Furukawa K; Sutandhio S; Tjan LH; Iwata S; Sano S; Tohma Y; Ohkita H; Nakamura S; Nishimura M; Arii J; Kiriu T; Yamamoto M; Nagano T; Nishimura Y; Mori Y J Infect Dis; 2022 Oct; 226(8):1391-1395. PubMed ID: 35512332 [TBL] [Abstract][Full Text] [Related]
8. Immediate reactions after mRNA SARS-CoV-2 vaccination. Jeimy S; Wong T; Song C CMAJ; 2021 Dec; 193(48):E1842. PubMed ID: 34772737 [No Abstract] [Full Text] [Related]
9. Comment on: mRNA SARS-CoV-2 vaccination in patients after allogeneic hematopoietic cell transplantation. Mungmunpuntipantip R; Wiwanitkti V Transpl Infect Dis; 2022 Jun; 24(3):e13839. PubMed ID: 35419913 [No Abstract] [Full Text] [Related]
10. SARS-CoV-2 mRNA Vaccination Is Not Associated With the Risk of Allosensitization in Patients Awaiting Kidney Transplantation. Zahradka I; Petr V; Modos I; Kabrtova K; Slavcev A; Viklicky O Transplantation; 2022 Dec; 106(12):e522-e524. PubMed ID: 36245078 [No Abstract] [Full Text] [Related]
11. Adverse cutaneous reactions after mRNA SARS-CoV-2 vaccination in 3 patients: a spectrum of severity. Edgerley S; Jeimy S; Zhu R CMAJ; 2022 Jun; 194(23):E807-E811. PubMed ID: 35697371 [No Abstract] [Full Text] [Related]
12. SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies. Wijtvliet VPWM; Verheyden S; Depreter B; Heylen C; Coeman E; Abrams S; De Winter BY; Massart A; Hellemans R; Pipeleers L; Claas FHJ; Ariën KK; Wissing KM; Abramowicz D; Ledeganck KJ Transpl Immunol; 2022 Oct; 74():101670. PubMed ID: 35835296 [TBL] [Abstract][Full Text] [Related]
13. Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination. Blixt L; Gao Y; Wullimann D; Murén Ingelman-Sundberg H; Muschiol S; Healy K; Bogdanovic G; Pin E; Nilsson P; Kjellander C; Grifoni A; Sette A; Sällberg Chen M; Ljunggren HG; Buggert M; Hansson L; Österborg A Blood; 2022 Dec; 140(22):2403-2407. PubMed ID: 36150168 [No Abstract] [Full Text] [Related]
14. Very severe immune aplastic anemia after mRNA vaccination against COVID-19 responds well to immunosuppressive therapy: clinical characteristics and comparison to previous reports. Woo S; Kim B; Lee SC; Kim MS; Yoon YA; Choi YJ Hematology; 2022 Dec; 27(1):1191-1195. PubMed ID: 36314944 [TBL] [Abstract][Full Text] [Related]
15. Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases. Fornaro M; Venerito V; Iannone F; Cacciapaglia F J Rheumatol; 2022 Mar; 49(3):334-335. PubMed ID: 35033998 [No Abstract] [Full Text] [Related]
16. Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses. Nam M; Yun SG; Kim SW; Kim CG; Cha JH; Lee C; Kang S; Park SG; Kim SB; Lee KB; Chung YS; Nam MH; Lee CK; Cho Y Microbiol Spectr; 2022 Aug; 10(4):e0249521. PubMed ID: 35946811 [TBL] [Abstract][Full Text] [Related]
17. Internet-based patient survey on the consequences of COVID-19 lockdown on treatment and medical follow-up of patients with aplastic anemia or paroxysmal nocturnal hemoglobinuria in Germany. Beier F; Kricheldorf K; Burmester P; Göbel U; Isfort S; Panse J; Brümmendorf TH Eur J Haematol; 2021 May; 106(5):740-742. PubMed ID: 33501692 [No Abstract] [Full Text] [Related]
18. Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients. Baron F; Canti L; Ariën KK; Kemlin D; Desombere I; Gerbaux M; Pannus P; Beguin Y; Marchant A; Humblet-Baron S Front Immunol; 2022; 13():827242. PubMed ID: 35309332 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 immunoglobulin G antibody levels in infants following messenger RNA COVID-19 vaccination during pregnancy. Kugelman N; Nahshon C; Shaked-Mishan P; Lavie O; Stein N; Kedar R; Waisman D Am J Obstet Gynecol; 2022 Dec; 227(6):911-913. PubMed ID: 35863460 [No Abstract] [Full Text] [Related]